Skip to Content

Diagnostics Portfolio

Roche’s Diagnostics Division is a leading supplier of in vitro diagnostics (IVDs): products used to test body fluids and tissue samples to obtain information for the purpose of diagnosing, preventing and treating disease.

Our leadership extends across the whole IVD spectrum, from centralised laboratory testing and point-of-care diagnostics to diabetes self-management. In addition, we supply cutting edge research tools to life scientists pursuing tomorrow’s medical advances. Research and development in the Business Areas focuses on disease areas where medical needs are great:

In 2012 Roche Diagnostics invested more than 900 million Swiss francs in developing technologies and products for launch in the coming years. The following key product launches are planned for 2012:

Key product launches planned for 2013

AreaProduct nameDescriptionMarket
Instruments/devices
Laboratoriescobas 8100next-generation modular pre-analyticsEU
Diabetes CareAccu-Chek Insightnext-generation insulin pump and blood glucose metreEU
Accu-Chek Activenext-generation blood glucose metre with maltose-independent test stripsEU
Life SciencesGS FLX+ Long ampliconssoftware for long-read targeted sequencing for DNA variant detectionWW
Tests/assays
OncologyCalcitoninimmunoassay, supports medullary thyroid cancer diagnosis and monitoringEU
proGRPimmunoassay, assists in the diagnosis of small cell lung cancerEU
EGFRPCR test, supports therapy selection for non-small cell lung cancerUS
ERIHC tissue test for breast cancer diagnosisUS
CINtec PLUS Cytologyimmunocytochemistry test for diagnosis of cervical pre-cancerEU
Infectious diseasesMPX 2.0PCR next-generation blood screening, multiplex test for HIV, HCV and HBVUS
HCV 2.0PCR next-generation HCV viral load testUS
TransplantationCyclosporin, Tacrolimusimmunoassays for monitoring of immunosuppressive drug therapyEU
SequencingSeqCap EZ Reagent Kitsfor sample preparation for targeted next-generation sequencingWW

Standard type = new product/first market launch; italic type = new product/launch in additional markets.

EU = European Union; US = United States; WW = worldwide.

ALK = anaplastic lymphoma kinase; CBL = Casitas B-cell lymphoma gene; CT/NG = Chlamydia trachomatis/Neisseria gonorrhoeae; EGFR = epidermal growth factor receptor; ER = estrogen receptor; GS = Genome Sequencer; HBV = hepatitis B virus; HCV = hepatitis C virus; HE4 = human epididymis secretory protein E4; HIV = human immunodeficiency virus; IHC = immunohistochemistry; ISH = in situ hybridisation; KRAS = member of the Ras family of oncogenes; p16 = protein p16INK4a; PCR = polymerase chain reaction; proGRP = pro-gastrin-releasing peptide; RUNX1 = Runt-related transcription factor 1; TET2 = member of the TET family of oncogenes.